Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May 17;123(19):2157-63.
doi: 10.1161/CIRCULATIONAHA.110.000943.

Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging

Denis B Buxton  1 , Melissa Antman, Narasimhan Danthi, Vasken Dilsizian, Zahi A Fayad, Mario J Garcia, Michael R Jaff, Michael Klimas, Peter Libby, Matthias Nahrendorf, Albert J Sinusas, Samuel A Wickline, Joseph C Wu, Robert O Bonow, Ralph Weissleder
Affiliations

Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging

Denis B Buxton et al. Circulation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr. Bonow received an honorarium from Ohio State University for a lecture on cardiovascular molecular imaging. Dr. Dilsizian reports receiving consulting fees and a research grant from GE Healthcare, and owns stock in GE Healthcare. Dr. Fayad has received research grants from Roche, Novartis, GlaxoSmithKline, Bristol Myers Squibb, VBL Therapeutics, and Merck, and has received consulting fees from Roche. Dr. Garcia owns stock in Pfizer and has advisory/consultancy relationships with MD Imaging, theheart.org, BG Medicine and the Intersocietal Accreditation Commission. Dr. Klimas is an employee of Merck. Dr. Libby has received in-kind research support from Astra Zeneca and Rigel Pharmaceuticals, and served on Advisory Boards for Interleukin Genetics, Novartis, VIA Pharmaceuticals, BIND Biosciences and Carolus Therapeutics. Dr. Sinusas has received research grants from Lantheus Medical Imaging, Astellas Pharma, GE Healthcare and Molecular Targeting Technologies, and has received consulting fees from Lantheus Medical Imaging and CDL Nuclear Technologies. Dr. Wickline serves on the advisory board and owns stock in Kereos. The remaining authors report no conflicts.

Figures

Figure 1
Figure 1. Cardiovascular molecular imaging publications from 1987 to 2010
The Scopus database was searched for the terms “molecular” and “imaging” in the title or abstract, and the results obtained were then restricted further by searching on “cardiovascular”. The results obtained from the restricted search were then checked manually to include only original research papers and to ensure relevance to “cardiovascular molecular imaging”
See this image and copyright information in PMC

References

    1. Jaffer FA, Libby P, Weissleder R. Optical and multimodality molecular imaging: Insights into atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1017–1024. - PMC - PubMed
    1. Jaffer FA, Vinegoni C, John MC, Aikawa E, Gold HK, Finn AV, Ntziachristos V, Libby P, Weissleder R. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation. 2008;118:1802–1809. - PMC - PubMed
    1. Upadhyay R, Sheth RA, Weissleder R, Mahmood U. Quantitative real-time catheter-based fluorescence molecular imaging in mice. Radiology. 2007;245:523–531. - PubMed
    1. Nahrendorf M, Sosnovik DE, French BA, Swirski FK, Bengel F, Sadeghi MM, Lindner JR, Wu JC, Kraitchman DL, Fayad ZA, Sinusas AJ. Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging. 2009;2:56–70. - PMC - PubMed
    1. Zacharakis G, Kambara H, Shih H, Ripoll J, Grimm J, Saeki Y, Weissleder R, Ntziachristos V. Volumetric tomography of fluorescent proteins through small animals in vivo. Proc Natl Acad Sci U S A. 2005;102:18252–18257. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources